Perrigo, Actavis, others file reply for timeliness judgment against US states' generic drug antitrust claims
MLex Summary: Perrigo, Actavis, Amneal, and other pharmaceutical companies filed reply in support of their motion for judgment against US states’ antitrust claims over generic drug pricing, saying that the facts...To view the full article, register now.
Already a subscriber? Click here to view full article